TIVICAY PD FDA approval date

The FDA approved TIVICAY PD on 12 Jun 2020.

FDA approval date
12 Jun 2020

Drug identity has not yet been verified against registry records

Also recorded as DOLUTEGRAVIR SODIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-06-12DayTIVICAY PDFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213983", "applicant_as_listed_by_fda": "VIIV HLTHCARE", "brand_names": ["TIVICAY PD"], "active_ingredients": ["DOLUTEGRAVIR SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200612", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026